Clinical Trials Browser

Approved for marketing × niraparib × Clear all

NCT05401214 2025-06-13

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Approved for marketing

Metastatic Castration-resistant Prostate Cancer

NCT03025867 2017-04-17

Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer

Approved for marketing

Ovarian Neoplasms